The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
نویسندگان
چکیده
Mazindol has been reported to improve muscle function in Duchenne muscular dystrophy (DMD) by virtue of its growth hormone (GH) suppression. The effects were studied on GH secretion (in response to growth hormone releasing factor and sleep) of mazindol 2 mg daily for 3 months in five boys with DMD. No consistent change was found following mazindol therapy. Adverse effects were noted in all the boys which may preclude long term use of mazindol in DMD.
منابع مشابه
Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.
Nine children with Duchenne muscular dystrophy were given Sanorex (mazindol), a growth hormone inhibitor, daily for 6 months. There was no significant change in their muscle function, but there was a significant reduction in weight gain and in levels of growth hormone, somatomedin C, hair zinc, serum zinc, and serum LDH. Selenium and glutathione peroxidase in the serum increased significantly. ...
متن کاملDetection of the Duplication in Exons 56-63 of Duchenne Muscular Dystrophy Patients with MLPA
Background Duchenne Muscular Dystrophy (DMD) is a deadly X-linked recessive disorder. This genetic disorder affects 1 among 3,500-5,000 males in the world. The majority of the patients are male, due to the type of inheritance. It affects most of the skeletal, the respiratory, and cardiac muscles, causing these vital organs to contract and eventually mortality.<br...
متن کاملSteroids in Duchenne dystrophy
0960-8966/$ see front matter 2013 Elsevier B.V. All rights re http://dx.doi.org/10.1016/j.nmd.2013.07.013 We read with interest the recent debate on steroids, growth and motor function decline in Duchenne muscular dystrophy (DMD) [1–3]. The efficacy and safety of growth hormone treatment in 39 ambulant DMD boys with glucocorticoid-induced growth failure was recently evaluated [3]. The authors o...
متن کاملP164: Adeno-Associated Viral Vectors in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (BMD) is an inherited X-link disease. The incidence of this muscle-wasting disease is 1:5000 male live births. Mutation in the gene coding for dystrophin is the main cause of BMD. Most cases of this disease succumb to respiratory and cardiac failure in 3rd to 4th decades. The slow progression of BMD and recent achievement of gene therapies make it as an appropriate c...
متن کاملSteroids in Duchenne muscular dystrophy.
Steroids in Duchenne muscular dystrophy In his commentary [1] on our recent publication on glucocorticoids in Duchenne muscular dystrophy (DMD) [2], Professor Dubowitz raises the interesting possibility that the prolonged ambulation in Duchenne boys on continuous therapy in contrast to the intermittent schedule may be related to the marked stunting of growth secondary to the higher dose of cort...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of neurology, neurosurgery, and psychiatry
دوره 51 12 شماره
صفحات -
تاریخ انتشار 1988